Overview

A Controlled Pregabalin Trial In Fibromyalgia

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of pregabalin compared with placebo for the relief of pain associated with fibromyalgia and improvement of function of patients with fibromyalgia
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin